{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:59:43Z","timestamp":1790251183374,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T00:00:00Z","timestamp":1738454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004609","name":"Foundation of Henan Educational Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004609","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009101","name":"Education Department of Henan Province","doi-asserted-by":"publisher","award":["24B320022"],"award-info":[{"award-number":["24B320022"]}],"id":[{"id":"10.13039\/501100009101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["242102311143"],"award-info":[{"award-number":["242102311143"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.tranon.2025.102319","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T22:55:39Z","timestamp":1739228139000},"page":"102319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Enhanced effect of radiofrequency ablation on HCC by siRNA-PD-L1-endostatin Co-expression plasmid delivered"],"prefix":"10.1016","volume":"53","author":[{"given":"Pengfei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Hei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhuang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenwang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tranon.2025.102319_bib0001","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"10127","key":"10.1016\/j.tranon.2025.102319_bib0002","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.tranon.2025.102319_bib0003","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.tranon.2025.102319_bib0004","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.08.065","article-title":"Epidemiology and management of hepatocellular carcinoma","volume":"156","author":"Kulik","year":"2019","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.tranon.2025.102319_bib0005","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","article-title":"Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020","volume":"134","author":"Cao","year":"2021","journal-title":"Chin. Med. J. (Engl)"},{"issue":"3","key":"10.1016\/j.tranon.2025.102319_bib0006","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5582\/bst.2021.01083","article-title":"Changes in and challenges regarding the surgical treatment of hepatocellular carcinoma in China","volume":"15","author":"Liu","year":"2021","journal-title":"Biosci. Trends."},{"issue":"2","key":"10.1016\/j.tranon.2025.102319_bib0007","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"10.1016\/j.tranon.2025.102319_bib0008","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41575-019-0179-x","article-title":"Insights into the success and failure of systemic therapy for hepatocellular carcinoma","volume":"16","author":"Bruix","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.tranon.2025.102319_bib0009","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"Suppl 1","key":"10.1016\/j.tranon.2025.102319_bib0010","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.tranon.2025.102319_bib0011","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cnc.2022.04.004","article-title":"Hepatocellular carcinoma","volume":"34","author":"Gilles","year":"2022","journal-title":"Crit. Care Nurs. Clin. North Am."},{"issue":"2","key":"10.1016\/j.tranon.2025.102319_bib0012","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s13304-020-00931-2","article-title":"Six months as a cutoff time point to define early recurrence after liver resection of hepatocellular carcinoma based on post-recurrence survival","volume":"73","author":"Liu","year":"2021","journal-title":"Updates. Surg."},{"issue":"1","key":"10.1016\/j.tranon.2025.102319_bib0013","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s40425-018-0391-1","article-title":"Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option","volume":"6","author":"Rohaan","year":"2018","journal-title":"J. ImmunOther Cancer"},{"issue":"2","key":"10.1016\/j.tranon.2025.102319_bib0014","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1148\/radiol.2021200153","article-title":"The 10-year survival analysis of radiofrequency ablation for solitary hepatocellular carcinoma 5 cm or smaller: primary versus recurrent HCC","volume":"300","author":"Bai","year":"2021","journal-title":"Radiology."},{"issue":"5","key":"10.1016\/j.tranon.2025.102319_bib0015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41575-020-00395-0","article-title":"Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma","volume":"18","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.tranon.2025.102319_bib0016","first-page":"553","article-title":"Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases","volume":"6","author":"Winkler","year":"2004","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.tranon.2025.102319_bib0017","first-page":"71","article-title":"Angiogenesis in residual cancer and roles of HIF-1\u03b1, VEGF, and MMP-9 in the development of residual cancer after radiofrequency ablation and surgical resection in rabbits with liver cancer","volume":"79","author":"Li","year":"2020","journal-title":"Folia Morphol. (Warsz)"},{"issue":"1","key":"10.1016\/j.tranon.2025.102319_bib0018","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1148\/radiol.2015150080","article-title":"Hepatic radiofrequency ablation-induced stimulation of distant tumor growth is suppressed by c-met inhibition","volume":"279","author":"Ahmed","year":"2016","journal-title":"Radiology."},{"issue":"6","key":"10.1016\/j.tranon.2025.102319_bib0019","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.tranon.2025.102319_bib0020","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1158\/2326-6066.CIR-19-0360","article-title":"Anti-VEGF treatment enhances CD8+ T-cell antitumor activity by amplifying hypoxia","volume":"8","author":"de Almeida","year":"2020","journal-title":"Cancer Immunol. Res."},{"issue":"3","key":"10.1016\/j.tranon.2025.102319_bib0021","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1535-6108(04)00057-1","article-title":"Endostatin's endpoints-deciphering the endostatin antiangiogenic pathway","volume":"5","author":"Benezra","year":"2004","journal-title":"Cancer Cell"},{"issue":"1\u20132","key":"10.1016\/j.tranon.2025.102319_bib0022","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.drup.2005.03.001","article-title":"Endostatin: the logic of antiangiogenic therapy","volume":"8","author":"Abdollahi","year":"2005","journal-title":"Drug Resist. Updat."},{"issue":"3","key":"10.1016\/j.tranon.2025.102319_bib0023","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1470-2045(06)70599-X","article-title":"Endostatin gene therapy inhibits tumour growth","volume":"7","author":"Passey","year":"2006","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.tranon.2025.102319_bib0024","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","article-title":"Systemic immunity in cancer","volume":"21","author":"Hiam-Galvez","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.tranon.2025.102319_bib0025","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2025.102319_bib0026","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01489-2","article-title":"Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions","volume":"21","author":"Yi","year":"2022","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.tranon.2025.102319_bib0027","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrclinonc.2016.58","article-title":"Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination","volume":"13","author":"Boutros","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.tranon.2025.102319_bib0028","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S1470-2045(19)30458-9","article-title":"Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a\/b trial","volume":"20","author":"Herbst","year":"2019","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.tranon.2025.102319_bib0029","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41573-019-0017-4","article-title":"The current state and future directions of RNAi-based therapeutics","volume":"18","author":"Setten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.tranon.2025.102319_bib0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi Therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2018","key":"10.1016\/j.tranon.2025.102319_bib0031","article-title":"Cancer immunotherapy: priming the host immune response with live attenuated Salmonella enterica","author":"Hernandez-Luna","year":"2018","journal-title":"J. Immunol. Res."},{"issue":"4","key":"10.1016\/j.tranon.2025.102319_bib0032","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.21037\/jgo-21-4","article-title":"Synergistic effects of arsenic trioxide combined with Salmonella typhimurium in treating the advanced hepatocellular carcinoma in rat models","volume":"12","author":"Zhao","year":"2021","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.tranon.2025.102319_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109127","article-title":"siRNA targeting PD-L1 delivered with attenuated Salmonella enhanced the anti-tumor effect of lenvatinib on mice bearing hepatocellular carcinoma","volume":"111","author":"Chen","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102319_bib0034","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41420-023-01603-x","article-title":"Attenuated Salmonella carrying siRNA-PD-L1 and radiation combinatorial therapy induces tumor regression on HCC through T cell-mediated immuno-enhancement","volume":"9","author":"Jia","year":"2023","journal-title":"Cell Death. Discov."},{"key":"10.1016\/j.tranon.2025.102319_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111728","article-title":"SiRNA-HIF-1\u03b1 delivered by attenuated Salmonella enhances the efficacy of Lenvatinib against hepatocellular carcinoma","volume":"130","author":"Chen","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.tranon.2025.102319_bib0036","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00262-012-1256-y","article-title":"Antitumor effects of Stat3-siRNA and endostatin combined therapies, delivered by attenuated Salmonella, on orthotopically implanted hepatocarcinoma","volume":"61","author":"Jia","year":"2012","journal-title":"Cancer Immunol. Immunther."},{"key":"10.1016\/j.tranon.2025.102319_bib0037","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.90911","article-title":"Nifuroxazide suppresses PD-L1 expression and enhances the efficacy of radiotherapy in hepatocellular carcinoma","volume":"12","author":"Zhao","year":"2024","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.tranon.2025.102319_bib0038","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1158\/2326-6066.CIR-22-0379","article-title":"Radiofrequency ablation remodels the tumor microenvironment and promotes neutrophil-mediated abscopal immunomodulation in pancreatic cancer","volume":"11","author":"Faraoni","year":"2023","journal-title":"Cancer Immunol. Res."},{"issue":"2","key":"10.1016\/j.tranon.2025.102319_bib0039","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001038","article-title":"Synergizing sunitinib and radiofrequency ablation to treat hepatocellular cancer by triggering the antitumor immune response","volume":"8","author":"Qi","year":"2020","journal-title":"J. ImmunOther Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2025.102319_bib0040","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102319_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.107313","volume":"50","author":"Dopazo","year":"2024","journal-title":"Eur. J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102319_bib0042","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1080\/02656736.2022.2059581","article-title":"Radiofrequency ablation in the treatment of hepatocellular carcinoma","volume":"39","author":"Deng","year":"2022","journal-title":"Int. J. Hyperthermia"},{"issue":"1","key":"10.1016\/j.tranon.2025.102319_bib0043","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-023-01725-x","article-title":"Roles of tumor-associated macrophages in anti-PD-1\/PD-L1 immunotherapy for solid cancers","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol. Cancer"},{"issue":"19","key":"10.1016\/j.tranon.2025.102319_bib0044","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1158\/0008-5472.CAN-20-0471","article-title":"Intratumoral copper modulates PD-L1 expression and influences tumor immune evasion","volume":"80","author":"Voli","year":"2020","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.tranon.2025.102319_bib0045","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1073\/pnas.1921445117","article-title":"Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy","volume":"117","author":"Wang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"issue":"7","key":"10.1016\/j.tranon.2025.102319_bib0046","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1158\/0008-5472.CAN-18-3208","article-title":"Anti-PD-L1 treatment results in functional remodeling of the macrophage compartment","volume":"79","author":"Xiong","year":"2019","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.tranon.2025.102319_bib0047","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00432-019-02879-2","article-title":"The role of PD-1\/PD-L1 axis and macrophage in the progression and treatment of cancer","volume":"145","author":"Cai","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.tranon.2025.102319_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1070961","article-title":"PD-1\/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.tranon.2025.102319_bib0049","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1158\/1078-0432.CCR-15-1352","article-title":"PD-1 blockade boosts radiofrequency ablation-elicited adaptive immune responses against tumor","volume":"22","author":"Shi","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.tranon.2025.102319_bib0050","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.dld.2023.09.019","article-title":"HIF-1\u03b1 and VEGF as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolization","volume":"56","author":"Pinto","year":"2024","journal-title":"Dig. Liver. Dis."},{"issue":"Suppl 3","key":"10.1016\/j.tranon.2025.102319_bib0051","article-title":"VEGF as a key mediator of angiogenesis in cancer","volume":"69","author":"Carmeliet","year":"2005","journal-title":"Oncology."},{"issue":"6","key":"10.1016\/j.tranon.2025.102319_bib0052","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1245\/s10434-007-9366-z","article-title":"High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies","volume":"14","author":"Poon","year":"2007","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2025.102319_bib0053","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11030718","article-title":"Endostatin and cancer therapy: a novel potential alternative to anti-VEGF monoclonal antibodies","volume":"11","author":"M\u00e9ndez-Vald\u00e9s","year":"2023","journal-title":"Biomedicines."},{"issue":"5","key":"10.1016\/j.tranon.2025.102319_bib0054","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s12094-018-1955-8","article-title":"Anti-tumor effect of endostatin in a sleep-apnea mouse model with tumor","volume":"21","author":"Zhang","year":"2019","journal-title":"Clin. Transl. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102319_bib0055","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12906-023-04120-7","article-title":"Anticancer potential of Bacillus coagulans MZY531 on mouse H22 hepatocellular carcinoma cells via anti-proliferation and apoptosis induction","volume":"23","author":"Zhao","year":"2023","journal-title":"BMC. Complement. Med. Ther."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325000506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325000506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:34:54Z","timestamp":1762562094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523325000506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":55,"alternative-id":["S1936523325000506"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102319","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced effect of radiofrequency ablation on HCC by siRNA-PD-L1-endostatin Co-expression plasmid delivered","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102319","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102319"}}